Deletion of macrophage migration inhibitory factor protects the heart from severe ischemia-reperfusion injury: A predominant role of anti-inflammation

Journal of Molecular and Cellular Cardiology

Volumn 50, Issue 6, 2011, Pages 991-999

  Gao, Xiao Ming ^a   Liu, Yang ^a   White, David ^a   Su, Yidan ^a   Drew, Brian G ^a   Bruce, Clinton R ^a   Kiriazis, Helen ^a   Xu, Qi ^a   Jennings, Nicole ^a   Bobik, Alex ^a   Febbraio, Mark A ^a   Kingwell, Bronwyn A ^a   Bucala, Richard ^c   Fingerle Rowson, Günter ^d   Dart, Anthony M ^a   Morand, Eric F ^b   Du, Xiao Jun ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b MONASH MEDICAL CENTRE   (Australia)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MACROPHAGE MIGRATION INHIBITION FACTOR; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR RELA;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENERGY METABOLISM; FATTY ACID OXIDATION; GENE DELETION; GLUCOSE TRANSPORT; HEART HEMODYNAMICS; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; GENE EXPRESSION REGULATION; HEMODYNAMICS; INFLAMMATION; INFLAMMATION MEDIATORS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; NEUTROPHIL INFILTRATION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

MUS;

EID: 79955646567     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.12.022     Document Type: Article

References (48)

1. Frangogiannis N.G., Smith C.W., Entman M.L. The inflammatory response in myocardial infarction. Cardiovasc Res 2002, 53:31-47.
2. Sambandam N., Lopaschuk G.D. AMP-activated protein kinase (AMPK) control of fatty acid and glucose metabolism in the ischemic heart. Prog Lipid Res 2003, 42:238-256.
3. Jordan J.E., Zhao Z.Q., Vinten-Johansen J. The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc Res 1999, 43:860-878.
4. Eefting F., Rensing B., Wigman J., Pannekoek W.J., Liu W.M., Cramer M.J., et al. Role of apoptosis in reperfusion injury. Cardiovasc Res 2004, 61:414-426.
5. Shibata R., Ouchi N., Ito M., Kihara S., Shiojima I., Pimentel D.R., et al. Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med 2004, 10:1384-1389.
6. Shibata R., Sato K., Pimentel D.R., Takemura Y., Kihara S., Ohashi K., et al. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat Med 2005, 11:1096-1103.
7. Hardie D.G. Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status. Endocrinology 2003, 144:5179-5183.
8. Young L.H., Li J., Baron S.J., Russell R.R. AMP-activated protein kinase: a key stress signaling pathway in the heart. Trends Cardiovasc Med 2005, 15:110-118.
9. Dolinsky V.W., Dyck J.R. Role of AMP-activated protein kinase in healthy and diseased hearts. Am J Physiol 2006, 291:H2557-H2569.
10. Calandra T., Bernhagen J., Metz C.N., Spiegel L.A., Bacher M., Donnelly T., et al. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 1995, 377:68-71.
11. Morand E.F., Leech M., Bernhagen J. MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis. Nat Rev Drug Discov 2006, 5:399-410.
12. Zernecke A., Bernhagen J., Weber C. Macrophage migration inhibitory factor in cardiovascular disease. Circulation 2008, 117:1594-1602.
13. Roger T., David J., Glauser M.P., Calandra T. MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 2001, 414:920-924.
14. Benigni F., Atsumi T., Calandra T., Metz C., Echtenacher B., Peng T., et al. The proinflammatory mediator macrophage migration inhibitory factor induces glucose catabolism in muscle. J Clin Invest 2000, 106:1291-1300.
15. Miller E.J., Li J., Leng L., McDonald C., Atsumi T., Bucala R., et al. Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart. Nature 2008, 451:578-582.
16. Ishii H., Ichimiya S., Kanashiro M., Amano T., Imai K., Murohara T., et al. Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment-elevation myocardial infarction. Circulation 2005, 112:1284-1288.
17. Moens A.L., Claeys M.J., Timmermans J.P., Vrints C.J. Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process. Int J Cardiol 2005, 100:179-190.
18. Gao X.M., Wang B.H., Woodcock E., Du X.J. Expression of active α1B-adrenergic receptors in the heart does not alleviate ischemic reperfusion injury. J Mol Cell Cardiol 2000, 32:1679-1686.
19. Gao X.M., Wong G., Wang B., Kiriazis H., Moore X.L., Su Y.D., et al. Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis. J Hypertens 2006, 24:1663-1670.
20. Fang L., Gao X.M., Moore X.L., Kiriazis H., Su Y., Ming Z., et al. Differences in inflammation, MMP activation and collagen damage account for gender difference in murine cardiac rupture following myocardial infarction. J Mol Cell Cardiol 2007, 43:535-544.
21. Drew B.G., Fidge N.H., Gallon-Beaumier G., Kemp B.E., Kingwell B.A. High-density lipoprotein and apolipoprotein AI increase endothelial NO synthase activity by protein association and multisite phosphorylation. Proc Natl Acad Sci USA 2004, 101:6999-7004.
22. Yang Y., Ma Y., Han W., Li J., Xiang Y., Liu F., et al. Age-related differences in postinfarct left ventricular rupture and remodeling. Am J Physiol 2008, 294:H1815-H1822.
23. Chen Z.P., Mitchelhill K.I., Michell B.J., Stapleton D., Rodriguez-Crespo I., Witters L.A., et al. AMP-activated protein kinase phosphorylation of endothelial NO synthase. FEBS Lett 1999, 443:285-289.
24. Frantz S., Ertl G., Bauersachs J. Toll-like receptor signaling in the ischemic heart. Front Biosci 2008, 13:5772-5779.
25. Yu C.M., Lai K.W., Chen Y.X., Huang X.R., Lan H.Y. Expression of macrophage migration inhibitory factor in acute ischemic myocardial injury. J Histochem Cytochem 2003, 51:625-631.
26. Yu C.M., Lau C.P., Lai K.W., Huang X.R., Chen W.H., Lan H.Y. Elevation of plasma level of macrophage migration inhibitory factor in patients with acute myocardial infarction. Am J Cardiol 2001, 88:774-777.
27. Jian Z., Li J.B., Ma R.Y., Chen L., Zhong Q.J., Wang X.F., et al. Increase of macrophage migration inhibitory factor (MIF) expression in cardiomyocytes during chronic hypoxia. Clin Chim Acta 2009, 405:132-138.
28. Amaral F.A., Fagundes C.T., Guabiraba R., Vieira A.T., Souza A.L., Russo R.C., et al. The role of macrophage migration inhibitory factor in the cascade of events leading to reperfusion-induced inflammatory injury and lethality. Am J Pathol 2007, 171:1887-1893.
29. Mitchell R.A., Liao H., Chesney J., Fingerle-Rowson G., Baugh J., David J., et al. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc Natl Acad Sci USA 2002, 99:345-350.
30. Dewald O., Ren G., Duerr G.D., Zoerlein M., Klemm C., Gersch C., et al. Of mice and dogs: species-specific differences in the inflammatory response following myocardial infarction. Am J Pathol 2004, 164:665-677.
31. Shibata M., Endo S., Inada K., Kuriki S., Harada M., Takino T., et al. Elevated plasma levels of interleukin-1 receptor antagonist and interleukin-10 in patients with acute myocardial infarction. J Interferon Cytokine Res 1997, 17:145-150.
32. Karpinski L., Plaksej R., Kosmala W., Witkowska M. Serum levels of interleukin-6, interleukin-10 and C-reactive protein in relation to left ventricular function in patients with myocardial infarction treated with primary angioplasty. Kardiol Pol 2008, 66:1279-1285.
33. Bolger A.P., Sharma R., von Haehling S., Doehner W., Oliver B., Rauchhaus M., et al. Effect of interleukin-10 on the production of tumor necrosis factor-α by peripheral blood mononuclear cells from patients with chronic heart failure. Am J Cardiol 2002, 90:384-389.
34. Kaur K., Sharma A.K., Dhingra S., Singal P.K. Interplay of TNF-α and IL-10 in regulating oxidative stress in isolated adult cardiac myocytes. J Mol Cell Cardiol 2006, 41:1023-1030.
35. Dhingra S., Sharma A.K., Arora R.C., Slezak J., Singal P.K. IL-10 attenuates TNF-α-induced NFκB pathway activation and cardiomyocyte apoptosis. Cardiovasc Res 2009, 82:59-66.
36. Garner L.B., Willis M.S., Carlson D.L., DiMaio J.M., White M.D., White D.J., et al. Macrophage migration inhibitory factor is a cardiac-derived myocardial depressant factor. Am J Physiol 2003, 285:H2500-H2509.
37. Chagnon F., Metz C.N., Bucala R., Lesur O. Endotoxin-induced myocardial dysfunction: effects of macrophage migration inhibitory factor neutralization. Circ Res 2005, 96:1095-1102.
38. Matsui Y., Okamoto H., Jia N., Akino M., Uede T., Kitabatake A., et al. Blockade of macrophage migration inhibitory factor ameliorates experimental autoimmune myocarditis. J Mol Cell Cardiol 2004, 37:557-566.
39. Yang J., Ding J.W., Chen L.H., Wang Y.L., Li S., Wu H. Sequential expression of TLR4 and its effects on the myocardium of rats with myocardial ischemia-reperfusion injury. Inflammation 2008, 31:304-312.
40. Oyama J., Blais C., Liu X., Pu M., Kobzik L., Kelly R.A., et al. Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice. Circulation 2004, 109:784-789.
41. Chao W. Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart. Am J Physiol 2009, 296:H1-H12.
42. Hall G., Hasday J.D., Rogers T.B. Regulating the regulator: NF-kappaB signaling in heart. J Mol Cell Cardiol 2006, 41:580-591.
43. Shimamoto A., Chong A.J., Yada M., Shomura S., Takayama H., Fleisig A.J., et al. Inhibition of Toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury. Circulation 2006, 114(1 Suppl):I270-I274.
44. Kudo N., Barr A.J., Barr R.L., Desai S., Lopaschuk G.D. High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5'-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase. J Biol Chem 1995, 270:17513-17520.
45. Randle P.J., Garland P.B., Newsholme E.A., Hales C.N. The glucose fatty acid cycle in obesity and maturity onset diabetes mellitus. Ann NY Acad Sci 1965, 131:324-333.
46. Koga K., Kenessey A., Powell S., Sison C.P., Miller E.J., Ojamaa K. Macrophage migration inhibitory factor provides cardioprotection during ischemia/reperfusion by reducing oxidative stress. Antioxid Redox Signal 2010 Sep 11, [Epub ahead of print].
47. Qi D., Hu X., Wu X., Merk M., Leng L., Bucala R., et al. Cardiac macrophage migration inhibitory factor inhibits JNK pathway activation and injury during ischemia/reperfusion. J Clin Invest 2009, 119:3807-3816.
48. Fingerle-Rowson G., Petrenko O., Metz C.N., Forsthuber T.G., Mitchell R., Huss R., Moll U., Müller W., Bucala R. The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting. Proc Natl Acad Sci USA 2003, 100:9354-9359.